Skip to content

Effect of cognitive behavior therapy on clinical outcome of patients with cervical persistent high-risk HPV infection

Effect of cognitive behavior therapy on clinical outcome of patients with cervical persistent high-risk HPV infection - RZXWHPV

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066570
Enrollment
Unknown
Registered
2022-12-09
Start date
2021-09-10
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

high-risk human papillomavirus infection

Interventions

psychological intervention treatment group:cognitive behavioral therapy
drug treatment group:interferon vaginal administration
Simple follow-up group: follow-up

Sponsors

Women and Children’s Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
21 Years to 60 Years

Inclusion criteria

Inclusion criteria: ? Patients aged 21-60 years who have sex and have HPV typing tests indicate that the same high-risk type of HPV (including single type infection and / or multiple types) in the cervical region has been continuously infected for more than 1 year; ? The first high-risk type of HPV was positive; ? Patients with PHQ-9 or GAD-7 = 5 points and diagnosed as emotional disorder by psychological evaluation; ? No abnormal cells were found in cervical cytology; ? Patients whose colposcopy indicates that cervical biopsy is not required or whose vulva, vagina, cervical precancerous lesions or cancer are excluded by biopsy; ? The sexual partner is fixed and has no history of sexual intercourse; ? During the study period, there was no family planning, and they could use condoms consistently; ? No previous neuropsychiatric disease, serious systemic disease and chronic disease; ? No major life events occurred in the family in the past 1 year; ? Normal expression and understanding ability and informed consent to the study; ? The clinical data were complete and the follow-up was reliable.

Exclusion criteria

Exclusion criteria: ? Family history of neuropsychiatric diseases; ? Cognitive impairment; ? Complicated with genital tract infection; ? Previous precancerous lesions or cancer of vulva, vagina and cervix; ? Previous genital warts; ? Previous cervical physical therapy history; ? Previous cervical surgery history; ? Combined with other organ tumors; ? Complicated with immune system disease or taking immunosuppressive drugs; ? Complicated with uncontrolled thyroid disease, diabetes and other important organ diseases; ? Smoking history; ? Drinking history; ? Unable to complete regular follow-up and reexamination; ? Pregnant and lactating women. ? Have a history of HPV vaccination.

Design outcomes

Primary

MeasureTime frame
High Risk Human Papillomavirus;

Secondary

MeasureTime frame
GAD-7 psychological scale score;PHQ-9 psychological scale score;

Countries

China

Contacts

Public ContactLong Xin

Women and Children’s Hospital of Chongqing Medical University

4261749@qq.com13608385160

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026